VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual tumor marker designed to provide artifact-free visibility across all major breast imaging ...
Patients with stage 1 or 2, hormone receptor (HR)-negative breast cancer had similar five-year rates of locoregional recurrence whether or not they underwent preoperative breast magnetic resonance ...
Susan G. Komen ®, the world's leading breast cancer organization commends Senator Hildy Angius (R-Bullhead City) for ...
Preoperative axillary ultrasound and MRI effectively predict sentinel lymph node status, guiding safe SLNB de-escalation in ...
Breast cancer survivors with dense breast tissue should be proactive in their screening approach, considering both 3D ...
New scans could triple the chance of finding some of the most difficult cases of breast cancer. The new techniques could discover an extra 3,500 breast cancers a year, detecting them much earlier, a ...
Susan G. Komen®, the world’s leading breast cancer organization commends Assemblymember Lori Wilson (D-Suisun City) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback